Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant

Abstract

New 1-substituted-biguanide derivatives 1–3 were synthesized by the reaction of 2,4-dimethoxyaniline, hydrazine and methylhydrazine with dicyandiamide in diluted hydrochloric acid. The resulting biguanide salts were fully characterized by spectroscopic methods. The synthesized compounds were screened for their anti-diabetic activity with standard metformin drug. Oral treatment of hyperglycemic rats with the synthesized biguanide derivatives (200 mg/kg/day) for 2 weeks significantly decreased the elevated blood glucose level. Oral administration of biguanide derivative 2 significantly decreased the level of total cholesterol. While, the triglycerides level was little decreased following administration of biguanide 1 as compared to hyperglycemic rats. Additionally, anti-diabetic properties towards liver function enzyme activities (AST and ALT) and kidney functions (urea and critinine) as well as histopathological studies relative to metformin hydrochloride were investigated and discussed.

Key words

diabetes mellitus - biguanides - metformin - anti-diabetic drug

• References

• 1 Skyler JS. Diabetes Mellitus:  Pathogenesis and Treatment Strategies. J Med Chem 2004; 47: 4113-4112
• 2 Hogan P, Dall T, Plamen N. Diabetes Care 2003; 26: 917
• 3 Cusi K, DeFronzo RA. Metformin: a review of its metabolic effects. Diabetes Rev 1998; 6: 89-131
• 4 Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174
• 5 (a) Hundal RS, Inzucchi SE. Drugs 2003; 63: 1879 (b) Evans J, Rushakoff R.J, Oral pharmacological agents for Type II Diabetes, University of Callifornia, 5 dec. 2010
• 6 Bamberger E, Dieckmann W. Ber. 1892; 25: 543
• 7 Hubberstey P, Suksangpanya U. Struct Bond 2004; 111: 33
• 8 Hundal RS, Inzucchi SE. Drugs. 2003; 63: 1879
• 9 Brzozowski Z, Sczewski F, Gdaniec M. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives. Eur J Med Chem 2000; 35: 1053-1064
• 10 Tsubouchi H, Ohguro K, Yasumura K et al. Synthesis and structure-activity relationships of novel antiseptics. Bioorganic & Medicinal Chemistry Letters 1997; 7: 1721-1724
• 11 Sweeney D, Raymer ML, Lockwood TD. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents. Biochemical Pharmacology 2003; 66: 663-677
• 12 Glennon RA, Daoud MK, Dukat M et al. Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: A QSAR study. Bioorg Med Chem 2003; 11: 4449-4454
• 13 Kaljurand I, Rodima T, Leito I et al. Self-Consistent Spectrophotometric Basicity Scale in Acetonitrile Covering the Range between Pyridine and DBU. Journal of Organic Chemistry 2000; 65: 6202-6208
• 14 Kovačević B, Maksić ZB. Basicity of Some Organic Superbases in Acetonitrile. Organic Letters 2001; 3: 1523-1526
• 15 Emerick AJ, Richards MP, Kartje GL et al. Diabetes 2005; 54: 2764-2771
• 16 Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann ClinBiochem 1969; 6: 24-27
• 17 Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med 1953; 41: 486-492
• 18 Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by colorimetric hantzsch condensation method. Dunn. Clin Chim Acta 1973; 19: 338-340
• 19 Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminase. Am J ClinPathol 1957; 28: 56-63
• 20 Wills MR, Savory J. Biochemistry of renal failure. Ann Clin Lab Sci 1981; 11: 292-299
• 21 Kroll MH, Roach NA, Poe B et al. Mechanism of interference with Jaffé reaction for creatinine. ClinChem 1987; 33: 1129-1132
• 22 Carleton H. Carleton’s. Histological Technique. 4^th ed. London, Oxford University Press; New York, Toronto: 1976